Charles B. O'Keeffe - 02 Jan 2024 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Director
Signature
/s/ Charles B. O'Keeffe
Issuer symbol
CPRX
Transactions as of
02 Jan 2024
Net transactions value
+$67,800
Form type
4
Filing time
03 Jan 2024, 17:18:58 UTC
Previous filing
29 Dec 2023
Next filing
16 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common Stock, par value $0.001 per share Options Exercise $67,800 +60,000 +9.7% $1.13 681,724 02 Jan 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -60,000 -20% $0.000000 232,931 02 Jan 2024 Common Stock 60,000 $1.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options vested in three annual tranches beginning on January 3, 2018.